Sorrento Therapeutics's total assets for Q2 2023 were $456.69M, a decrease of -0.73% from the previous quarter. SRNE total liabilities were $654.65M for the fiscal quarter, a 11.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.